Hybridan Small Cap Feast: 27/03/2025

* A corporate client of Hybridan LLP

** Potential means Intention to Float (ITF) has been announced, or it is a rumour

***Arranged by type of listing and date of announcement

****Alphabetically arranged

Share prices and market capitalisations taken from the current price on the day of publication

Dish of the day

Admissions:  

None

Delistings:  

Cmo Group plc (CMO.L) left AIM today.

What’s baking in the oven?

Upcoming Market Movers:

6 February: Creightons (CRL.L) has announced an intention to move to AIM from the Main Market. It is expected that the last day of dealings in the Ordinary Shares on the Main Market will be 28 March 2025. Dealing in the Ordinary Shares is expected to commence on AIM, at 8.00 a.m. on 31 March.

Potential**  Initial Public Offerings:

17th March: MHA, a professional services provider of audit and assurance, tax, accountancy, and advisory services and independent UK member of Baker Tilly International, announced its Intention to Float on the AIM Market.  The Group is seeking to raise up to £125m to provide growth capital for the Company as well as enabling a sell down by certain partners.  Alongside the Placing, the Group intends to launch a retail offer to raise up to approximately £6m.

17th March: Quantum Base, the quantum science Company, announced its intention to apply for Admission to trading on the AIM Market during April 2025.  Quantum Base is a quantum science company creating a new global standard in authentication through its patented Quantum Identities - near unbreakable and non-replicable authenticity tags that can be applied to a vast array of products, significantly mitigating counterfeiting, and can be authenticated with a smartphone.  The Company is seeking to raise between £3m-£5m through a placing, alongside a retail offer.

18th March: Uranium Energy Exploration, to be renamed The Smarter Web Company (AQSE:SWC) is a UK-based web design agency, specialising in creating bespoke, mobile-friendly websites and offers a range of online marketing strategies to help businesses enhance their online presence. Services include various web design packages, logo design, Search Engine Optimisation, animation and custom development. It is looking to do a fundraise of £2m on AQSE. Admission expected 2 April.

Banquet Buffet****

The UK drug delivery company focused on the localised delivery of chemotherapy drugs, announced that it has been awarded a grant by Innovate UK to support the pre-clinical development of the Company's proprietary ChemoSeed technology in prostate cancer. The Project is in line with the Company's strategy as detailed in the admission document published when CRISM joined the AIM market last year and which highlighted the potential of ChemoSeed in multiple disease areas. The Innovate UK grant was awarded as part of the Government's  'Launchpad: life and health sciences, Northern Ireland - Rd2 MFA'. Under the terms of the grant, CRISM will develop a docetaxel-loaded implantable drug delivery technology for intraprostatic chemotherapy, addressing the critical need for localised, effective, and less toxic prostate cancer treatment. 



The operator of Domino's pizza stores and restaurants across Poland and Croatia, has announced the acquisition of the entire issued share capital of Mastergrupa sp z.o.o., trading as Pizzeria 105 in Poland, a franchised quick service pizza restaurant business that operates 90 locations across Poland. The total consideration for the shares in Pizzeria 105 amounted to PLN 42.3m (c. £8.5m). Simultaneously the seller of Pizzeria 105, Marcin Ciesielski has agreed to re-invest one third of the Consideration through its family office, MC Family Fundacja Rodzinna, equating to c.PLN 13.4m (c.£2.7m) by subscribing for 23,582,322 new ordinary shares of 0.5 pence each in the Company at the subscription price of 11.4 pence per Ordinary Share.



The specialist staffing group, reports FY for December 2024. Its Net Fee Income (NFI) is 6% lower at £50.4m leading to a 25% reduction in Adjusted Operating  Profit to  £3.8m . The loss before tax is £5.5m compared to a marginal profit of £0.1m. This substantial loss reflects adjustments including the amortisation of intangible assets, impairment of goodwill  and exceptional items such as the loss on sale of subsidiaries. The adjusted net debt increased 41% to £15.3m with headroom of £4.1m. The company is taking decisive steps to accelerate  strategy by concentrating on core sectors in the UK and the US.



The chip maker of mixed signal ASICs (Application Specific Integrated Circuits), has announced that it has been awarded an $18m design and supply contract by a European based supplier of electromechanical products for an Arm-based mixed signal sensor interface ASIC to be used across a range of automotive and industrial applications. The total value of the Contract includes significant Non-Recurring Engineering (NRE) payments and supply revenues, which is estimated to exceed $18m over 7 years, based on quoted NRE fees and forecast production volumes.  The Contract will commence in April 2025, with NRE revenues falling into EnSilica's current and next financial years, with supply revenues forecast to commence during 2027. 



The global energy storage innovator, today announced a strategic cooperation agreement with the Max Planck Institute (MPI), Potsdam, to develop high-power, high-cycle life sulfur batteries with high energy densities. The partnership brings together Gelion's battery technology designs with MPI's breakthrough nano-confined carbon/sulfur composite cathode and anode material technologies. The novel sulfur composite technology has been successfully tested by MPI in sodium-sulfur cells, demonstrating both long cycle life (many hundreds of cycles) and high-power capabilities (10C), highlighting its potential for use in long duration stationary storage as well as EVs, leveraging off its low-cost materials and its fast-charging characteristics (below 10 minutes). The agreement enables Gelion to integrate the technologies, designs and expertise of both parties to fully demonstrate MPI's nano-confined materials - initially in coin and then in larger, commercially relevant pouch cell formats - for both Na-S and Li-S batteries.



The strategic energy and precious minerals exploration and development company, has today provided an update relating to the Company's critical minerals exploration portfolio in Ontario, Canada. The Company's 100%-owned Iva Lithium Project has been expanded to include newly interpreted pegmatite targets prospective for the mineralisation of lithium-bearing minerals over a trend extending 5.5 km. The Iva Lithium Project expanded from 640 hectares (6.4 km2) to 1,130 hectares to encompass an inferred 5.5 km trend of pegmatites prospective for lithium mineralisation. The number of known, historically mapped pegmatites and newly inferred pegmatites interpreted from LiDAR2, on the property has doubled.



The mobile media company has announced that it has been notified that the online casino and sportsbook, known previously to MOS shareholders as Bet, has successfully launched in Mexico. After a successful VIP testing phase, the brand named Estadio Gana has officially launched its Sports Book and Casino platform to the Mexican public. As of today, Mexican sports enthusiasts and gaming fans can now place bets on Estadio Gana 's platform, offering betting and gaming experiences. This launch marks Estadio Gana's entry into one of the world's fastest-growing sports betting markets. Mexico's sports betting and gaming industry is projected to reach a market size of US$11.47b by the end of 2025 according to Yogonet Gaming News, with further growth expected to go up to 70% by 2028. As a nation passionate about sports and gaming, and with Mexico set to co-host the FIFA World Cup in 2026, the industry is primed for exponential expansion.



The information technology company reports Interims to December 2024 and there has been a significant evolution following acquisitions. Over 80% of its £32.2m sales come from audio Visual, Cyber Security or Network Infrastructure. Gross profits increased 27.5% to £5.1m with margins up from 14% to 16.1%. This reflects the continued exit from lower margin commodity and the clear strategic focus on value add, higher margin, technical distribution. The Operating loss however increased 4.5% to £486,000. The cash reserves are marginally up at £2.6m with Net Assets at £21.7m which include two mortgage free freehold properties. An interim Dividend of 0.3p is being paid and the management will continue  to review organic and acquisitive growth opportunities. 



The workforce benefits and health insurance provider, today announced it has renewed and expanded its partnership with Sage Group plc, the leader in accounting, financial, HR and payroll technology for small and mid-sized businesses, with a new contract for a minimum of three years. The expanded partnership includes the ability to offer Sage Employee Benefits across multiple different solutions within Sage's portfolio, enabling more Sage customers to gain access to the benefits platform. The contract is expected to deliver over double the number of referrals currently being provided by Sage. Sage Employee Benefits is the Group's digital workforce engagement platform for SMBs created and sold in partnership with Sage. Since launch in 2017, the offering has grown to reach over 62,000 paying employees. In 2024, all customers were successfully transitioned onto the next generation of the platform. 



The oil and gas company with a high-impact exploration asset in Jamaica and a development asset in the UK, has announced that it has secured an early two-year extension to the Walton Morant licence offshore Jamaica, now valid until 31 January 2028, where it holds a 100% working interest. The extension provides UOG with the security required to advance discussions with farm-in partners and progress technical work, reinforcing the significant exploration potential of this licence. With the extended tenure confirmed, United have re-engaged with selected parties who had previously expressed interest before the farm-out process was suspended in December 2024, as well as new interest from additional groups. At present, multiple companies are under Non-Disclosure Agreements (NDAs) and actively reviewing data as part of the farm-out process.



 

This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.

This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.

The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.

References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results.  Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.

To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).

Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.

In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.